Alexander A. Girgis

Alexander A. Girgis

Auto-generated profile, based on publicly available information

Alexander A. Girgis

Convergence Institute, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2024 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
DSDaniel H. Shu
Daniel H. Shu
WHWon Jin Ho
Won Jin Ho
LKLuciane Kagohara
Luciane Kagohara
AGAlexander Girgis
Alexander Girgis
SSSarah M. Shin
Sarah M. Shin
MYMark Yarchoan
Mark Yarchoan

29 March 2021 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
SKSamantha B Kemp
Samantha B Kemp
NSNina G Steele
Nina G Steele
ECEileen S Carpenter
Eileen S Carpenter
KDKatelyn L Donahue
Katelyn L Donahue
GBGrace G Bushnell
Grace G Bushnell
MMMarina Pasca di Magliano
Marina Pasca di Magliano
Pancreatic ductal adenocarcinoma (PDA) is accompanied by reprogramming of the local microenvironment, but changes at distal sites are poorly understood. We implanted biomaterial scaffolds, which act as an artificial premetastatic niche, into immunocompetent tumor-bearing and control mice, and identified a unique tumor-specific gene expression signature that includes high expression of C1qa, C1qb, Trem2, and Chil3. Single-cell RNA sequencing mapped these genes to two distinct macrophage populations in the scaffolds, one marked by elevated C1qa, C1qb, and Trem2, the other with high Chil3, Ly6c2 and Plac8. In mice, expression of these genes in the corresponding populations was elevated in tumor-associated macrophages compared with macrophages in the normal pancreas. We then analyzed single-cell RNA sequencing from patient samples, and determined expression of C1QA, C1QB, and TREM2 is elevated in human macrophages in primary tumors and liver metastases. Single-cell sequencing analysis of patient blood revealed a substantial enrichment of the same gene signature in monocytes. Taken together, our study identifies two distinct tumor-associated macrophage and monocyte populations that reflects systemic immune changes in pancreatic ductal adenocarcinoma patients.

24 February 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
ACAshley M. Curran
Ashley M. Curran
AGAlexander A. Girgis
Alexander A. Girgis
YJYura Jang
Yura Jang
JCJonathan D. Crawford
Jonathan D. Crawford
MTMekha A. Thomas
Mekha A. Thomas
EDErika Darrah
Erika Darrah
Cryptic peptides, hidden from the immune system under physiologic conditions, are revealed by changes to MHC class II processing and hypothesized to drive the loss of immune tolerance to self-antigens in autoimmunity. Rheumatoid arthritis (RA) is an autoimmune disease characterized by immune responses to citrullinated self-antigens, in which arginine residues are converted to citrullines. Here, we investigate the hypothesis that citrullination exposes cryptic peptides by modifying protein structure and proteolytic cleavage. We show that citrullination alters processing and presentation of autoantigens, resulting in the generation of a unique citrullination-dependent repertoire composed primarily of native sequences. This repertoire stimulates T cells from RA patients with anti-citrullinated protein antibodies more robustly than controls. The generation of this unique repertoire is achieved through altered protease cleavage and protein destabilization, rather than direct presentation of citrulline-containing epitopes, suggesting a novel paradigm for the role of protein citrullination in the breach of immune tolerance in RA.

19 October 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
DSDaniel H. Shu
Daniel H. Shu
WHWon Jin Ho
Won Jin Ho
LKLuciane Kagohara
Luciane Kagohara
AGAlexander Girgis
Alexander Girgis
SSSarah M. Shin
Sarah M. Shin
MYMark Yarchoan
Mark Yarchoan
Neoadjuvant immunotherapy is thought to produce long-term remissions through induction of antitumor immune responses before removal of the primary tumor. Tertiary lymphoid structures (TLS), germinal center-like structures that can arise within tumors, may contribute to the establishment of immunological memory in this setting, but understanding of their role remains limited. Here, we investigated the contribution of TLS to antitumor immunity in hepatocellular carcinoma (HCC) treated with neoadjuvant immunotherapy. We found that neoadjuvant immunotherapy induced the formation of TLS, which were associated with superior pathologic response, improved relapse free survival, and expansion of the intratumoral T and B cell repertoire. While TLS in viable tumor displayed a highly active mature morphology, in areas of tumor regression we identified an involuted TLS morphology, which was characterized by dispersion of the B cell follicle and persistence of a T cell zone enriched for ongoing antigen presentation and T cell-mature dendritic cell interactions. Involuted TLS showed increased expression of T cell memory markers and expansion of CD8 + cytotoxic and tissue resident memory clonotypes. Collectively, these data reveal the circumstances of TLS dissolution and suggest a functional role for late-stage TLS as sites of T cell memory formation after elimination of viable tumor. Graphical Highlights: In patients with hepatocellular carcinoma (HCC), tertiary lymphoid structures (TLS) are induced by neoadjuvant immunotherapy and are associated with favorable clinical outcomes. TLS within the same tumor demonstrate extensive sharing of expanded granzyme K and granzyme B-expressing CD8 + T effector memory clonotypes, but the B cell repertoires of individual TLS are almost wholly distinct, consistent with independent germinal center reactions. Within areas of viable tumor, mature TLS are characterized by high expression of CD21 and CD23, BCL6 + germinal center B cells, and close interactions between DCLAMP + mature dendritic cells and CXCR5 - CXCR3 + CD4 T peripheral helper cells within a T cell zone adjacent to the B cell follicle. Within areas of tumor regression, an involuted TLS morphology is identified that is notable for dissolution of the B cell germinal center, retention of the T cell zone, and increased T cell memory.

15 August 2025 in Cancer Immunology Research
Verified
Journal Article
Closed access
DSDimitrios N. Sidiropoulos
Dimitrios N. Sidiropoulos
SSSarah M. Shin
Sarah M. Shin
MWMeredith Wetzel
Meredith Wetzel
AGAlexander A. Girgis
Alexander A. Girgis
DBDaniel Bergman
Daniel Bergman
LKLuciane Kagohara
Luciane Kagohara
Pancreatic ductal adenocarcinoma (PDAC) is a rapidly progressing cancer that responds poorly to immunotherapies. Intratumoral tertiary lymphoid structures (TLS) have been associated with rare long-term PDAC survivors, but the role of TLS in PDAC and their spatial relationships within the context of the broader tumor microenvironment remain unknown. In this study, we report the generation of a spatial multiomic atlas of PDAC tumors and tumor-adjacent lymph nodes from patients treated with combination neoadjuvant immunotherapies. Using machine learning–enabled hematoxylin and eosin image classification models, imaging mass cytometry, and unsupervised gene expression matrix factorization methods for spatial transcriptomics, we characterized cellular states within and adjacent to TLS spanning distinct spatial niches and pathologic responses. Unsupervised learning identified TLS-specific spatial gene expression signatures that are significantly associated with improved survival in patients with PDAC. We identified spatial features of pathologic immune responses, including intratumoral TLS–associated B-cell maturation colocalizing with IgG dissemination and extracellular matrix remodeling. Our findings offer insights into the cellular and molecular landscape of TLS in PDACs during immunotherapy treatment.

17 April 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
MTMekha A. Thomas
Mekha A. Thomas
PNPooja Naik
Pooja Naik
HWHong Wang
Hong Wang
JGJon T. Giles
Jon T. Giles
AGAlexander A. Girgis
Alexander A. Girgis
EDErika Darrah
Erika Darrah
Although anti-citrullinated protein autoantibodies (ACPAs) are a hallmark serological feature of rheumatoid arthritis (RA), the mechanisms and cellular sources behind the generation of the RA citrullinome remain incompletely defined. Peptidylarginine deiminase IV (PAD4), one of the key enzymatic drivers of citrullination in the RA joint, is expressed by granulocytes and monocytes; however, the subcellular localization and contribution of monocyte-derived PAD4 to the generation of citrullinated autoantigens remain underexplored. In this study, we demonstrate that PAD4 displays a widespread cellular distribution in monocytes, including expression on the cell surface. Surface PAD4 was enzymatically active and capable of citrullinating extracellular fibrinogen and endogenous surface proteins in a calcium dose–dependent manner. Fibrinogen citrullinated by monocyte-surface PAD4 could be specifically recognized over native fibrinogen by a panel of eight human monoclonal ACPAs. Several unique PAD4 substrates were identified on the monocyte surface via mass spectrometry, with citrullination of the CD11b and CD18 components of the Mac-1 integrin complex being the most abundant. Citrullinated Mac-1 was found to be a target of ACPAs in 25% of RA patients, and Mac-1 ACPAs were significantly associated with HLA-DRB1 shared epitope alleles, higher C-reactive protein and IL-6 levels, and more erosive joint damage. Our findings implicate the monocyte cell surface as a unique and consequential site of extracellular and cell surface autoantigen generation in RA.